Introduction {#s1}
============

Mitochondria evolved from a single endosymbiotic event between an ancestral alpha-proteobacterium and an archaeon-related host cell. During the gradual conversion of the endosymbiont into an organelle, most of the many genes encoded in the genome of the proto-mitochondrion were either lost or transferred to the host genome ([@bib61]; [@bib3]; [@bib18]). The mitochondrial genes that are now encoded in the nucleus, are translated on cytosolic ribosomes and imported into the various mitochondrial subcompartments. Mitochondrial protein import is executed by several protein complexes, which were thought to be well conserved ([@bib55]; [@bib30]). How these translocase complexes originally evolved is important for understanding early eukaryotic evolution specifically, and host-symbiont integration, more generally. However, as mitochondria have a billion-year history and can be traced back to the Last Eukaryotic Common Ancestor (LECA) ([@bib61]), it is difficult to gain unambiguous information about their origin and diversification. Although (nearly [@bib38]) all eukaryotes have mitochondria or related organelles, recent studies have shown that mitochondria and their import apparatuses are considerably diverse ([@bib22]; [@bib32]; [@bib45]; [@bib28]; [@bib27]). Thus, it is important to investigate variation across eukaryotes in order to understand how these absolutely essential import systems have evolved and diversified over the last billion years of eukaryotic evolution.

Mitochondrial protein import has best been studied in *Saccharomyces cerevisiae* and much of this work can, in principle, be generalized to most eukaryotic lineages. However, more recent work has also characterized mitochondrial import pathways in the parasitic protozoan *Trypanosoma brucei*. These investigations have revealed the extreme divergence of the *T. brucei* import machinery compared to other eukaryotes ([@bib32]; [@bib63]). The translocase of the outer membrane (TOM) complex in *S. cerevisiae* comprises seven subunits, of which three are conserved across all eukaryotic lineages and can be traced to LECA ([@bib45]; [@bib43]; [@bib46]). On the other hand, the atypical translocase of the outer membrane (ATOM) in trypanosomes also consists of seven subunits, but only two of these are shared with all eukaryotes ([@bib45]; [@bib46]; [@bib44]). In the case of the translocase of the inner membrane (TIM) complexes, the situation is even more extreme. Most eukaryotes have two TIM complexes (TIM22 and TIM23) which do not have any subunits in common ([@bib32]; [@bib76]; [@bib47]). The TIM22 complex is specialized for membrane insertion of proteins that contain multiple membrane-spanning domains such as mitochondrial carrier proteins ([@bib24]; [@bib56]). The TIM23 complex mediates membrane translocation and insertion of presequence-containing proteins ([@bib55]; [@bib30]; [@bib47]; [@bib50]). Surprisingly, trypanosomes have only a single TIM complex that, with minor variations, functions in both import of presequence-containing and carrier proteins ([@bib31]). The only TIM complex component shared between trypanosomes and other eukaryotes is TbTim17 ([@bib31]; [@bib67]), an orthologue of the Tim22 subunit of the TIM22 complex ([@bib76]; [@bib58]).

How and why did these extreme changes in the trypanosomal TIM complex occur? Is the divergence observed due to some unseen selective pressure, or could it have evolved through neutral evolutionary processes ([@bib69]; [@bib42]; [@bib74])? To start addressing these questions, here we focused on the presequence translocase-associated motor (PAM) of *T. brucei*.

In order to translocate presequence-containing proteins, the TIM23 complex must associate with the matrix-localized PAM, which in yeast, consists of five essential subunits ([@bib47]; [@bib65]; [@bib15]). These are (i) the mitochondrial heat shock protein 70 (mHsp70) ([@bib35]; [@bib37]) and (ii) its nucleotide exchange factor Mge1, which mediate the transport of presequence-containing substrates across the mitochondrial membranes; (iii) Tim44 which recruits mHsp70 to Tim23 ([@bib4]), the pore-forming subunit of the TIM23 complex.; (iv) Pam18, a J protein with an N-terminal transmembrane domain (TMD) that stimulates ATP hydrolysis of mHsp70 ([@bib17]; [@bib70]; [@bib49]), and is itself regulated by associating with (v) the soluble J-like protein Pam16 ([@bib40]; [@bib25]). These PAM subunits are relatively well conserved across eukaryotes ([@bib27]).

We predict that the single bifunctional *T. brucei* TIM complex needs to associate with a PAM complex to import presequence-containing proteins into the matrix. However, the nature of this trypanosomal PAM is presently unknown. Single trypanosomal orthologues of mHsp70 and Mge1 are readily identified, and an ORF resembling Tim44 (Tb927.7.4620) is detected through HHPred profile-profile analyses. Furthermore, a number of J and J-like proteins are present in the mitochondrial proteome of *T. brucei*, including putative orthologues of Pam 16 and 18 ([@bib27]).

Here, we confirm the identity of the Pam16 and Pam18 orthologues in the mitochondrion of *T. brucei* and we demonstrate that they, surprisingly, do not function in the PAM complex. Instead, we show that the J protein TbPam27 is an essential component of the trypanosomal PAM. This suggests that TbPam27 convergently evolved to replace the function of the ancestral Pam18 in kinetoplastids, probably via neutral evolutionary processes.

Results {#s2}
=======

Identification of J domain-containing putative PAM subunits in *T. brucei* {#s2-1}
--------------------------------------------------------------------------

We searched for J domain-containing proteins that could be part of the PAM complex that cooperates with the single bifunctional TIM complex of *T. brucei*. To do so, we first built a protein similarity network of the J protein superfamily from a set of 46 diverse representative eukaryotes ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We identified four clusters in this network that correspond to putative PAM subunits and selected them for further experimental analyses ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Two clusters correspond to the Pam16 and Pam18 subfamilies of J proteins which are found in diverse eukaryotic representatives, including euglenozoans (e.g., kinetoplastids, diplonemids and euglenids). Moreover, two euglenozoan-specific clusters were of note. One was of special interest since its member in *T. brucei* is a 27 kDa protein (Tb927.10.13830, termed TbPam27) previously found to be associated with the single trypanosomal TIM complex ([@bib31]). Finally, our analysis revealed another kinetoplastid-specific cluster whose member in *T. brucei* is Tb927.4.650 and which appeared closest in similarity to Pam18 and Pam16 in profile Hidden Markov Model (HMM) searches. Thus, our network and phylogenetic analysis ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) of J proteins confirms that *T. brucei* has not only orthologues of Pam16 (Tb927.9.13530, termed TbPam16) and Pam18 (Tb927.8.6310, termed TbPam18) ([@bib27]) but also kinetoplastid-specific J proteins of which TbPam27 appears to be associated with the TIM complex.

![Sequence analysis of the J protein superfamily in eukaryotes and euglenozoans.\
(**A**) Similarity network of DnaJ and Pam16 domain-containing proteins clustered by CLANS with a P-value threshold value of 1 × 10^−12^. A cohesive Pam18 cluster is recovered (blue), as well as a more diffused Pam16 cluster (red). Two smaller and cohesive Kinetoplastea-specific clusters corresponding to Pam27 (green) and Tb927.4.650 (orange) are also recovered. (**B**) Condensed phylogenetic tree inferred by IQ-TREE and the best-fitting LG+R5 model from the Pam16, Pam18, Pam27 and Tb927.4.650 clusters identified in the protein similarity network (see [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} for a fully annotated phylogenetic tree). Thick branches represent branch support values higher than 70% SH-aLRT and 70% UFBoot2+NNI. Only representative protein sequences corresponding to *Saccharomyces cerevisiae* S288C and *Trypanosoma brucei brucei* TREU927 are labeled. The phylogenetic tree recovers clades that correspond to the clusters identified by the protein similarity network. Phylogenetic tree is arbitrarily rooted in the internal branch between the Pam27 and all other clades. - For species name, phylogenetic affiliation and database source for each of the predicted proteomes used in the similarity network and phylogenetic analyses see [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}.\
Figure 1---source data 1.Species name, phylogenetic affiliation and database source for each of the predicted proteomes used in the similarity network and phylogenetic analyses.](elife-52560-fig1){#fig1}

TbPam27, but not TbPam18, TbPam16 or Tb927.4.650, is associated with the TIM complex {#s2-2}
------------------------------------------------------------------------------------

We then tested whether the four J proteins identified through our bioinformatic analyses are localized to mitochondria. Cell extractions with low concentration of digitonin show that the four C-terminally epitope-tagged proteins co-fractionate with the mitochondrial marker ATOM40 ([Figure 2A](#fig2){ref-type="fig"}). Moreover, the four proteins are all present in the mitochondrial proteome defined by ImportOmics ([@bib54]). All proteins are also exclusively recovered in the pellet when a crude mitochondrial fraction is subjected to carbonate extraction at high pH, suggesting they are integral membrane proteins ([Figure 2B](#fig2){ref-type="fig"}). Protease protection experiments additionally show that TbPam27, TbPam18 and TbPam16 remain intact in crude mitochondrial fractions and are only digested when the membrane barrier is destroyed by detergent. This indicates that all three tagged proteins are localized inside a membrane-bound compartment ([Figure 2C](#fig2){ref-type="fig"}). Finally, normalized abundance profiles of TbPam27 over six subcellular fractions, produced in a previous proteomic analysis ([@bib52]), assign it to the mitochondrial inner membrane (IM) ([Figure 2D](#fig2){ref-type="fig"}).

![TbPam27, TbPam18, TbPam16 and Tb927.4.650 are inner mitochondrial membrane proteins.\
(**A**) Immunoblot analysis of total cells (T), digitonin-extracted mitochondria-enriched (M) and soluble cytosolic (S) fractions of cells expressing the indicated C-terminally myc- or HA-tagged proteins. The immunoblots were probed with anti-tag antibodies and antisera against ATOM40 and elongation factor 1-alpha (EF1a), which serve as markers for mitochondria and cytosol, respectively. (**B**) Digitonin-extracted mitochondria-enriched fractions (T) were subjected to alkaline carbonate extraction performed at pH 11.5 resulting in membrane-enriched pellet (P) and soluble supernatant (S) fractions. Subsequent immunoblots were decorated with anti-tag antibodies and antisera against ATOM40 and cytochrome C (Cyt C), which serve as markers for integral membrane and soluble proteins, respectively. (**C**) Digitonin-extracted mitochondria-enriched fractions were subjected to a protease protection assay. Subsequent immunoblots were probed with anti-tag antibodies. TbmHsp70 and ATOM69 served as control for matrix and OM proteins, respectively. (**D**) Normalized abundance profile of TbPam27 over six subcellular fractions produced in a previous proteomic analysis ([@bib52]).](elife-52560-fig2){#fig2}

Immunoprecipitation (IP) experiments, in which tagged TbPam27 is used as the bait, efficiently recovers the TIM subunits TbTim17 and TimRhom I ([Figure 3A](#fig3){ref-type="fig"}, left most panel). However, the same is not the case when tagged TbPam18, TbPam16 or Tb927.4.650 are used as baits ([Figure 3A](#fig3){ref-type="fig"}). To analyze the relation of the four candidate proteins to the single trypanosomal TIM complex in more detail, we surveyed the three previously published SILAC (stable isotope labeling by amino acids in cell culture)-IP experiments of TIM subunits ([@bib31]). In these experiments TbTim17, TbTim42 and the small Tim protein TbTim13, a fraction of which is tightly associated with the TIM complex, were used as the baits ([@bib31]; [@bib73]). Moreover, we also performed an analogous SILAC-IP experiment, using the C-terminally triple myc-tagged TIM subunit acyl-CoA dehydrogenase (ACAD) as the bait. The results of all four SILAC-IP experiments are summarized in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. The figure depicts the relative enrichment factors for our candidate proteins and for the detected TIM core subunits, compared to the epitope-tagged bait proteins. Interestingly, TbPam27 was efficiently enriched in three out of four experiments. TbPam18, TbPam16 and Tb927.4.650, however, were either not detected in any of the four experiments, or in the case of TbPam16, in the ACAD pull down experiment, not enriched. Thus, TbPam27, but not TbPam18, TbPam16 or Tb927.4.650, is associated with the trypanosomal TIM. This is remarkable, since our protein similarity network shows that TbPam27 is more similar to other members of the J protein superfamily, than to TbPam16 and TbPam18 ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We, therefore, decided to carry out the reciprocal SILAC-IP experiments, using C-terminally HA-tagged TbPam18 and TbPam16 as baits. For TbPam16, the protein that was enriched the most and significantly detected, besides the bait, was TbPam18 (5.7-fold), suggesting that the two proteins interact. Most importantly, however, neither of the eight detected TIM subunits was enriched ([Figure 3B](#fig3){ref-type="fig"}, left panel; [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}). In the TbPam18-HA SILAC-IP many more proteins were found to be enriched ([Figure 3B](#fig3){ref-type="fig"}, right panel; [Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). Unexpectedly, essentially all the proteins with the highest significant enrichment are either annotated as ER proteins or predicted to be involved in ER-related processes, such as glycosylation or glycosyl-phosphatidyl inositol (GPI) anchoring. Of all the detected mitochondrial proteins, in contrast, only TbPam18 itself was enriched more than 3-fold, and the 11 detected TIM subunits show only a marginal enrichment of 1.6--1.8-fold, considering the 26.3-fold enrichment of the bait. TbPam16 was not detected, which suggests that the C-terminal tag of TbPam18 might prevent the interaction between the two proteins.

![TbPam27, but not TbPam18, TbPam16 and Tb927.4.650, is associated with the TIM complex.\
(**A**) Cell lines expressing the indicated C-terminally triple myc- or HA-tagged proteins were subjected to co-immunoprecipitation (CoIP). 5% each of crude mitochondrial fractions (Input) and unbound proteins (Unbound), as well as 100% of the final eluates (IP) were separated by SDS-PAGE. The resulting immunoblots were probed with anti-tag antibodies and antisera against TIM subunits (TbTim17 and TimRhom I) and VDAC. (**B**) SILAC-IP experiments of TbPam16-HA and TbPam18-HA from digitonin-extracted mitochondria enriched fractions. Volcano plots show the mean log~10~ ratios (induced/uninduced) of proteins that were detected in at least two of three independent biological replicates by quantitative MS, plotted against the corresponding -log~10~ P values (one-sided t-test). The vertical dotted lines specify the indicated enrichment factors. The horizontal dotted line indicates a t-test significance level of 0.05. Green dots represent proteins that are found in the mitochondrial proteome ([@bib54]), red dots indicate TIM subunits and pink dots represent proteins that are enriched more than three-fold and which, according to the TriTryp database (<https://tritrypdb.org/tritrypdb/>), are ER-localized or have a putative ER-associated function.\
Figure 3---source data 1.List of proteins identified by SILAC-MS from a pull down experiment of mitochondria-enriched fractions using C-terminally myc-tagged ACAD as a bait.\
Figure 3---source data 2.List of proteins identified by SILAC-MS from a pull down experiment of mitochondria-enriched fractions using C-terminally HA-tagged TbPam16 as a bait.\
Figure 3---source data 3.List of proteins identified by SILAC-MS from a pull down experiment of mitochondria-enriched fractions using C-terminally HA-tagged TbPam18 as a bait.](elife-52560-fig3){#fig3}

In summary, these results confirm that neither TbPam16 nor TbPam18 is associated with the trypanosomal TIM complex. Moreover, based on the SILAC-IP results presented above, it seems that a fraction of TbPam18 might localize to the ER. It is important to note that the SILAC-IPs presented here, were carried out with crude mitochondrial fractions obtained by digitonin extractions ([Figure 2](#fig2){ref-type="fig"}). In these crude mitochondrial fractions significant amounts of the ER are present. Moreover, both TbPam16 and TbPam18 contain predicted N-terminal mitochondrial targeting sequences. Thus, it is unlikely that the ER localization of TbPam18 is an artefact caused by the C-terminal epitope-tag. Attempts to localize TbPam18 and TbPam16 by immunofluorescence, were not successful, because the signals for TbPam18 and TbPam16 were not strong enough for this type of analysis.

TbPam27 is part of the active presequence translocase {#s2-3}
-----------------------------------------------------

Using import arrested substrates, it has previously been shown that trypanosomes have a single TIM complex that, with minor variations, mediates import of both presequence-containing and carrier proteins ([@bib31]). The only identified difference between the two forms of the complex was that the two rhomboid-like proteins, TimRhom I and TimRhom II, were specifically associated with the presequence translocase. To investigate whether TbPam27 is associated with the active presequence translocase, we co-expressed TbPam27-myc with a fusion protein. This fusion protein is composed of the presequence and part of the mature form (1--160 aa) of the trypanosomal matrix protein dihydrolipoyl dehydrogenase (LDH), and mouse dihydrofolate reductase (DHFR) carrying a C-terminal triple HA-tag. Addition of aminopterin to this cell line irreversibly fixes the DHFR in its 3D conformation, causing the LDH part of the substrate to be stuck in both the ATOM and the TIM complex ([@bib31]; [@bib64]). [Figure 4A](#fig4){ref-type="fig"} shows that CoIP experiments using the stuck substrate in the presence of aminopterin as the bait, not only recover the LDH-DHFR-HA along with ATOM40 and the TIM components TbTim17 and TimRhom I, as expected, but also the myc-tagged TbPam27. Moreover, the reverse experiment, using TbPam27-myc as the bait, precipitates the very same proteins LDH-DHFR-HA, ATOM40, TbTim17 and TimRhom I. However, only negligible amounts of the OM protein VDAC, which was used as a control, were recovered in either of the two experiments.

![TbPam27 is part of the active presequence translocase but not of the active carrier translocase.\
(**A**) Left: Schematic representation of the stalled presequence intermediate induced by in vivo expression of the LDH-DHFR fusion protein in presence of aminopterin (AMT). Right: Digitonin-solubilized mitochondrial extracts from cells co-expressing LDH-DHFR-HA and TbPam27-myc which were grown in presence of AMT and subjected to co-immunoprecipitation (CoIP) using either the HA- (left panel) or myc-tag (right panel). (**B**) Left: Schematic depiction of the stalled carrier intermediate induced by the expression of a truncated mitochondrial carrier protein (MCPΔI). Right: Digitonin-solubilized mitochondrial extracts from cells co-expressing MCP12ΔI-myc and TbPam27-HA were subjected to CoIP using either the HA- (left panel) or myc-tag (right-panel). For all CoIPs 5% each of crude mitochondrial fractions (Input) and unbound proteins (Unbound), as well as 100% of the final eluate (IP) were separated by SDS-PAGE. The resulting immunoblots were probed with anti-tag antibodies and antisera against ATOM40, TIM subunits (TbTim17 and TimRhom I), VDAC and Cox IV as indicated. The two bands shown for LDH-DHFR-HA, represent the LDH-DHFR-HA portions without (lower band) or with bound AMT (higher band).](elife-52560-fig4){#fig4}

To investigate whether TbPam27 is also part of the active carrier translocase, we co-expressed C-terminally triple HA-tagged TbPam27 (TbPam27-HA) with a truncated version of the C-terminally myc-tagged carrier protein MCP12 (MCP12ΔI-myc). This substrate was previously shown to accumulate in the TIM complex, engaged in carrier protein import, because it lacks the two N-terminal TMDs ([@bib31]; [@bib7]). IP experiments in [Figure 4B](#fig4){ref-type="fig"} using anti-myc antibodies, show that TbTim17 was efficiently co-precipitated with MCP12ΔI-myc, but that only marginal amounts of TbPam27-HA were recovered in the eluate. Moreover, as expected, the presequence translocase-specific TimRhom I, as well as cytochrome oxidase subunit 4 (Cox IV), remained in the unbound fraction. Conversely, IP using TbPam27-HA efficiently precipitated TbTim17 and TimRhom I, whereas MCP12ΔI-myc and Cox IV were not recovered.

The results discussed above, are in line with data obtained in a previous study, which analyzed CoIP experiments using the stuck LDH-DHFR precursor or the import-arrested truncated carrier protein as baits by SILAC proteomics ([@bib31]). [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} depicts the obtained enrichment factors for TbPam27, TbPam18 and TbPam16 as well as for the indicated TIM subunits relative to the TIM core subunit TbTim17. The figure illustrates that TbPam27 is much higher enriched in the presequence rather than the carrier translocase SILAC-IP. Moreover, TbPam16 and TbPam18 are either not detected in these experiments or enriched to a lesser extent than the control protein VDAC.

In summary, these experiments show that TbPam27, but neither TbPam16 nor TbPam18, is specifically associated with the active presequence translocase.

TbPam27 with an intact J domain is essential for mitochondrial protein import {#s2-4}
-----------------------------------------------------------------------------

To investigate the function of TbPam27, we produced an inducible RNAi cell line. [Figure 5A](#fig5){ref-type="fig"}, left panel shows that ablation of TbPam27 causes a rapid growth arrest and a concomitant accumulation of unprocessed Cox IV. Importantly, the levels of TbTim17, one of the core subunits of the trypanosomal TIM complex, are not affected. Previous work has shown that accumulation of precursor Cox IV indicates that mitochondrial import of presequence-containing proteins is inhibited ([@bib54]; [@bib57]). Essentially identical results as for TbPam27 RNAi were obtained when the analogous experiment was done for the single trypanosomal mitochondrial heat shock protein 70 (TbmHsp70). TbmHsp70, as shown before, is required for matrix protein import ([@bib71]; [Figure 5A](#fig5){ref-type="fig"}, right panels). These results show that TbPam27 and TbmHsp70 are essential for growth and that their function is linked to mitochondrial protein import.

![TbPam27 is essential and requires an intact J domain for its function.\
(**A**) Top panel: Growth curves of uninduced (-Tet) and induced (+Tet) procyclic TbPam27 and TbmHsp70 RNAi cell lines. Error bars correspond to the standard deviation (n = 3). Insets show Northern blots of total RNA from uninduced or two days induced cells which were probed for the corresponding mRNAs. Ethidiumbromide-stained rRNAs serve as loading controls. Arrows indicate the onset of the protein import phenotype. Bottom panels: Immunoblot analysis of steady-state protein levels of Cox IV and TbTim17 in whole-cell extracts of the respective RNAi cell line. (**B**) Top panel: Growth curves of uninduced (-Tet) and induced (+Tet) TbPam27 RNAi cell lines targeting the 5' UTR that ectopically either express wildtype TbPam27 (TbPam27^wt^) or a version of TbPam27 carrying the H77Q mutation (TbPam27^H77Q^). Insets show Northern blots of total RNA from uninduced and two days induced cells, probed for the TbPam27 ORF. The top bands correspond to the endogenous and the bottom bands to the ectopically expressed TbPam27 versions. Ethidiumbromide-stained rRNAs serve as loading controls. Bottom panel: Immunoblot analysis of steady-state protein levels of Cox IV in whole-cell extracts of the respective cell line. In (**A**) and (**B**) EF1a or VDAC serve as loading control. The positions of Cox IV precursor (P) and mature (M) forms are indicated. (**C**) Growth curve of the uninduced (-Tet) and induced (+Tet) bloodstream form (BSF) γL262P RNAi cell line ablating TbPam27. Error bars correspond to the standard deviation (n = 3). Insets show Northern blots of total RNA from uninduced or two days induced cells which were probed for the corresponding mRNAs. Ethidiumbromide-stained rRNAs serve as loading controls.](elife-52560-fig5){#fig5}

Trypanosomes have a complex life cycle alternating between an insect vector, the Tsetse fly, and a mammalian host. The insect-stage procyclic form of the parasite has highly active mitochondria capable of oxidative phosphorylation. The mitochondrion of the bloodstream form, on the other hand, lacks the respiratory complexes, except for the ATP-synthase which functions in reverse ([@bib62]). Mitochondrial protein import, however, is essential for both the insect stage and bloodstream form of trypanosomes ([@bib16]). Thus, should TbPam27 indeed be required for protein import, it will be essential in the bloodstream form as well. We tested this using an inducible TbPam27 RNAi cell line of the *T. brucei* bloodstream strain γL262P ([@bib20]). The result in [Figure 5C](#fig5){ref-type="fig"} shows that TbPam27, indeed, is also essential for normal growth of *T. brucei* bloodstream forms.

In yeast and humans, Pam18, but not Pam16, requires an intact J domain for its function ([@bib17]; [@bib19]; [@bib68]). To study whether this is also the case for TbPam27, we produced an RNAi cell line targeting the 5\' untranslated region (UTR) of the TbPam27 mRNA. Such a cell line can be used for complementation experiments provided the TbPam27 open reading frame (ORF) is expressed in the context of a different 5\' UTR. The left panels in [Figure 5B](#fig5){ref-type="fig"} show that, as expected, ectopic expression of untagged TbPam27 in the 5\' UTR RNAi cell line restores growth to nearly wild-type levels and prevents Cox IV precursor accumulation. However, when the same experiment was performed with a variant of TbPam27 containing a single H to Q substitution at position 77 in the conserved HPD motif of the J domain, no complementation was observed ([Figure 5B](#fig5){ref-type="fig"}, right panels). Cell growth was arrested and accumulation of Cox IV precursor, just as the TbPam27 RNAi cell line alone, was observed. The Northern blots in [Figure 5AB](#fig5){ref-type="fig"} confirm that endogenous TbPam27 mRNA is efficiently down regulated in all RNAi cell lines. The lower bands in the Northern blots shown in [Figure 5B](#fig5){ref-type="fig"} furthermore demonstrate that similar amounts of the ectopically expressed TbPam27 mRNAs are produced in the two complemented cell lines.

Thus, TbPam27, as yeast and human Pam18, but unlike Pam16, requires an intact J domain to exert its function.

Neither TbPam16 nor TbPam18 is required for mitochondrial protein import {#s2-5}
------------------------------------------------------------------------

We also produced inducible RNAi cell lines of procyclic *T. brucei* for TbPam18, TbPam16 and Tb927.4.650. [Figure 6A](#fig6){ref-type="fig"} shows that ablation of TbPam18 and TbPam16 causes a growth arrest and an accumulation of unprocessed Cox IV. However, unlike for TbPam27, precursor accumulation was only observed two days after the growth phenotype became apparent, suggesting that it is an indirect effect. Ablation of Tb927.4.650, on the other hand, affected cell-growth only slightly and caused no Cox IV precursor accumulation.

![Ablation of TbPam18 and TbPam16 affects growth of procyclic form but not of bloodstream form trypanosomes.\
(**A**) Upper panels: Growth curves of uninduced (-Tet) and induced (+Tet) procyclic TbPam18, TbPam16 and Tb927.4.650 RNAi cell lines. Arrows indicate the onset of the mitochondrial protein import phenotype. Bottom panels: Immunoblot analysis of steady-state protein levels of Cox IV and TbTim17 in whole-cell extracts of the respective RNAi cell lines. EF1a serves as loading control. The positions of Cox IV precursor (P) and mature (M) forms are indicated. (**B**) Growth curve of the uninduced (-Tet) and induced (+Tet) blood stream form (BSF) γL262P RNAi cell lines ablating TbPam18 or TbPam16. In (**A**) and (**B**) error bars correspond to the standard deviation (n = 3). Insets show Northern blots of total RNA from uninduced or two days induced cells which were probed for the corresponding mRNAs. Ethidiumbromide-stained rRNAs serve as loading controls.](elife-52560-fig6){#fig6}

As discussed above, TbPam18 and TbPam16 are not associated with the TIM complex. This result strongly suggests that they are not involved in mitochondrial protein import. To further analyze the functions of TbPam18 and TbPam16, we tested whether the two proteins are essential for normal growth of the bloodstream form γL262P cell line. The results in [Figure 6B](#fig6){ref-type="fig"} show that, in contrast to what was seen for TbPam27 ([Figure 5C](#fig5){ref-type="fig"}), this is not the case. This result indicates that neither TbPam18 nor TbPam16 have an essential function in mitochondrial protein import. Thus, while we do not know what the essential functions of TbPam16 and TbPam18 are, they are limited to the procyclic form.

TbPam16 and TbPam18 are not associated with the TIM complex and not involved in protein import. Could it be that the two proteins function as a backup system in the absence of TbPam27? In order to test whether TbPam16 or TbPam18 are recruited to TIM complex in the absence TbPam27, we expressed tagged versions of each of the proteins in the TbPam27 RNAi cell line. The results in [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"} show that neither TbPam16 nor TbPam18 accumulate in the absence of TbPam27. Moreover, CoIP experiments, in which TbPam18-HA or TbPam16-HA in TbPam27 depleted cells were used as baits, still do not recover the TIM subunits TbTim17 or TimRhom I ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Thus, TbPam18 and TbPam16 are not associated with the TIM complex, irrespectively whether TbPam27 is present or not.

TbPam27 is required for the formation of the presequence pathway intermediate {#s2-6}
-----------------------------------------------------------------------------

Formation of the stalled presequence pathway intermediate ([Figure 4A](#fig4){ref-type="fig"}) in the presence of aminopterin is expected to depend on an active PAM module ([@bib66]), which pulls the unfolded moiety of the LDH-DHFR-myc precursor across the ATOM and the TIM complexes into the matrix. Formation of the carrier intermediate, however, should be independent of the PAM module ([@bib10]). Blue native (BN)-PAGE analysis demonstrates that LDH-DHFR-myc accumulates in a high molecular weight complex corresponding to the import intermediate that is stuck in the import complexes as shown in the left panel of [Figure 7A](#fig7){ref-type="fig"}. However, complex formation is largely abolished in induced TbPam27 RNAi cells after the time point, when the arrest in growth becomes apparent. As a positive control, the analogous experiment was done in a TbmHsp70 RNAi cell line, and essentially the same result was obtained ([Figure 7A](#fig7){ref-type="fig"}, right panel). These results demonstrate that both, TbPam27 and TbmHsp70, are required for the formation of the stalled presequence pathway intermediate.

![TbPam27 is required for the formation of the presequence but not for the carrier intermediate.\
(**A**) Left: Schematic representation of the stalled presequence intermediate induced by in vivo expression of the LDH-DHFR fusion protein in presence of aminopterin (AMT). Right, upper panels: BN-PAGE analysis of the presequence intermediate in cell lines expressing HA- or myc-tagged LDH-DHFR in the background of RNAi against either TbPam27 or TbmHsp70 as indicated. Cells were grown in the absence or presence (0.5 days) of AMT as specified. (**B**) Left: Schematic depiction of the stalled carrier intermediate induced by the expression of the truncated mitochondrial carrier protein (MCPΔI). Right, upper panel: BN-PAGE analysis of the carrier intermediate in a cell line expressing myc-tagged MCP12ΔI in the background of RNAi against TbPam27. For all experiments digitonin-extracted mitochondrial fractions were prepared after the indicated number of days of RNAi induction and separated on a 4--13% BN-PAGE. The resultant immunoblots were probed with anti-tag antibodies. Coomassie-stained gel sections (Coom.) serve as loading controls. In (**A**) and (**B**) the right, lower panels show SDS-PAGE analysis of whole-cell extracts of the respective cell lines. Immunoblots were probed with anti-tag antibodies, to demonstrate a constant LDH-DHFR-myc/-HA or MCP12ΔI-myc expression. The two bands shown for LDH-DHFR-myc/-HA, represent the LDH-DHFR-myc/-HA portions without (lower band) or with bound AMT (higher band). Probing for TbTim17 demonstrates integrity of the TIM complex. (**C**) Densitometric quantification of the BN-PAGE signals to compare the amounts of LDH-DHFR-myc (as shown in A) and MCP12ΔI-myc (as shown in B) in the TbPam27-RNAi cell line found in the respective high molecular weight complexes. The levels after 0.5 days of RNAi induction were set to 100%. Error bars correspond to the standard error of the mean of three biological replicates.](elife-52560-fig7){#fig7}

Interestingly, accumulation of the truncated MCP12ΔI-myc at the TIM complex was not affected by ablation of TbPam27 for at least 2 days ([Figure 7B](#fig7){ref-type="fig"}). Thus, as expected for a PAM subunit, ablation of TbPam27 selectively interferes with the formation of the stalled presequence intermediate but not with formation of the carrier intermediate ([Figure 7C](#fig7){ref-type="fig"}).

Stalling of the presequence pathway intermediate was also analyzed in the TbPam18 and TbPam16 cell lines, whose ablation caused Cox IV precursor accumulation albeit at late time points only ([Figure 6](#fig6){ref-type="fig"}). [Figure 8](#fig8){ref-type="fig"} shows that ablation of neither of the two proteins interferes with the formation of the import arrested presequence-containing substrate.

![Ablation of neither TbPam18 nor TbPam16 does affect the formation of the presequence intermediate.\
Left: Schematic representation of the stalled presequence intermediate induced by in vivo expression of the LDH-DHFR fusion protein in presence of aminopterin (AMT). Right: BN-PAGE analysis of the presequence intermediate in cell lines expressing myc-tagged LDH-DHFR in the background of RNAi against either TbPam18 or TbPam16 as indicated. Experiments were done exactly as described in [Figure 7A](#fig7){ref-type="fig"}.](elife-52560-fig8){#fig8}

Ablation of TbPam27 preferentially affects presequence-containing proteins {#s2-7}
--------------------------------------------------------------------------

To determine the import of which substrate proteins is affected by TbPam27 ablation, we performed a quantitative proteomic analysis of the steady-state levels of mitochondrial proteins in the TbPam27 RNAi cell line. To do so, we used SILAC combined with high-resolution mass spectrometry (MS). Uninduced and induced TbPam27 RNAi cells were grown in medium containing different stable isotope-labelled forms of arginine and lysine. After 1.5 days of RNAi induction equal cell numbers of uninduced and induced cultures were mixed and mitochondria-enriched fractions were prepared for further analysis by quantitative MS. At this time point, growth of the induced cells is essentially identical to the uninduced ones ([Figure 5A](#fig5){ref-type="fig"}). The proteins detected in this analysis, were filtered for mitochondrial proteins, using the recently published mitochondrial proteome of *T. brucei* ([@bib54]). It has previously been shown that a reduction in the abundance of mitochondrial proteins in these types of experiments, is mainly due to inhibition of mitochondrial protein import ([@bib54]; [@bib57]). We detected 899 mitochondrial proteins, which corresponds to 83% of the previously determined proteome ([@bib54]), and of which 34.4% are downregulated more the 1.5-fold. ([Figure 9A](#fig9){ref-type="fig"}). Of all detected mitochondrial proteins, 66.5% contain predicted mitochondrial presequences ([Figure 9B](#fig9){ref-type="fig"}). 39.6% of the presequence-containing proteins show more than 1.5-fold decreased steady-state levels 1.5 days after TbPam27 RNAi induction. However, only 24.6% of the remaining mitochondrial proteins, that presumably have internal targeting sequences (excluding the 12 detected carrier proteins), are reduced more than 1.5-fold ([Figure 9C](#fig9){ref-type="fig"}). Finally, looking specifically at the mitochondrial carrier proteins, we found that only one of them is more than 1.5-fold downregulated (8.3%) ([Figure 9D](#fig9){ref-type="fig"}).

![Global mitochondrial proteome changes upon ablation of TbPam27.\
Digitonin-extracted mitochondria-enriched fractions of uninduced and 1.5 days induced TbPam27 RNAi cells were subjected to SILAC-based quantitative MS. The mean log~2~ of normalized ratios (induced/uninduced) was plotted against the corresponding -log~10~ P value (two sided t-test). (**A**) Volcano plot depicts all mitochondrial proteins identified in this experiment ([@bib54]). (**B**) Volcano plot shows proteins with a predicted mitochondrial targeting sequence (MTS) ([@bib1]). Numbered red dots and the respective protein names below the figure, correspond to the five most downregulated, significantly detected proteins besides TbPam27. (**C**) Volcano blot depicts the remaining other mitochondrial proteins, which were detected in this experiment, besides mitochondrial carrier proteins (MCPs), which are shown in (**D**). Numbers in parentheses specify how many proteins were detected in each subset. The horizontal dotted line indicates a t-test significance level of 0.05. The vertical dotted lines mark a fold-change in protein abundance of ±1.5 in each plot. The blue background indicates a downregulation of 1.5-fold. The percentage of proteins that are downregulated more than 1.5-fold in each sub-dataset is indicated in the upper left corner of each panel. For a list of all proteins identified in the SILAC-MS experiment see [Figure 9---source data 1](#fig9sdata1){ref-type="supplementary-material"}.\
Figure 9---source data 1.List of proteins identified in SILAC-MS experiments of mitochondria-enriched fractions from TbPam27 RNAi cells.](elife-52560-fig9){#fig9}

In summary, these experiments show that ablation of TbPam27, as expected for a PAM subunit, preferentially affects the presequence pathway. The results also demonstrate that ablation of TbPam27 does not affect the levels of TIM complex subunits ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}), indicating that the trypanosomal TIM complex and the putative PAM complex are separate entities.

Discussion {#s3}
==========

In contrast to all other major eukaryotic lineages, kinetoplastids have a single bifunctional TIM complex which facilitates the import of both, mitochondrial presequence-containing and mitochondrial carrier proteins. Here, we show that TbPam27 is an essential mitochondrial IM protein. It is associated with the presequence translocase but not with the carrier translocase version of the trypanosomal TIM and functions analogously to fungal Pam18. Like Pam18, TbPam27 is an integral IM protein and requires an intact J domain for its function. However, unlike Pam18 subfamily members, which have N-terminal TMDs, TbPam27 is C-terminally anchored in the IM membrane. Consequently, the J domain of TbPam27 has a reverse orientation relative to the IM when compared to Pam18 of yeast and humans ([@bib49]). It is unclear if this topological reorientation is functionally significant.

PAM has been studied in-depth exclusively in fungi and animals. There are some data which show that *Trichomonas* and *Giardia* Pam18s localize to hydrogenosomes and mitosomes, respectively ([@bib59]; [@bib21]). A rudimentary functional conservation has been demonstrated as the J domain of the *Trichomonas* Pam18 can complement the J domain of *S. cerevisiae* Pam18 ([@bib59]). The PAM subunit Tim44 has orthologues in essentially all eukaryotes ([@bib12]) including *Trichomonas* and *Giardia* ([@bib58]; [@bib59]; [@bib48]). Trypanosomes, on the other hand, lack a clear Tim44 orthologue ([@bib58]; [@bib48]). A protein, whose C-terminal domain shows similarity to Tim44 by HHPred has been identified in *T. brucei*. However, it has been shown that this protein is not associated with the trypanosomal TIM complex ([@bib31]). These data suggest that *Trichomonas* and *Giardia* may have a somewhat conventional PAM complex. The TIM-PAM complex in *T. brucei* is thus an outlier. Therefore, it constitutes an excellent system to investigate how a process can be evolutionarily conserved in the midst of sequence divergence and component replacement ([@bib74]).

Surprisingly, *T. brucei* retains orthologues of Pam16 and Pam 18 in its mitochondrion. However, we show that neither of the two proteins is associated with the TIM complex, nor does their ablation interfere with the formation of the presequence pathway intermediate. Furthermore, unlike TbPam27, they are not essential for the bloodstream form of *T. brucei*. These data indicate that they are not subunits of the trypanosomal PAM. Instead, the ancestral function of Pam18 has likely been taken over by TbPam27. Previous examples of convergent evolution for the mitochondrial protein import system of *T. brucei* have been described. They include the two OM import receptors ATOM46 and ATOM69 ([@bib44]) as well as pATOM36 ([@bib72]). In these cases, functionally similar proteins convergently evolved likely due to similar selective pressures.

In the case of the TIM complex of kinetoplastids, we have a different story. Previous work has shown that LECA most likely already had both, TIM23 and TIM22 complexes ([@bib27]; [@bib76]; [@bib58]). Thus, how an ancestor with two specialized import systems evolved to have a single bifunctional TIM complex is a curious affair. We suggest that a neutral replacement of the ancestral Pam18, and possibly also Pam16, by TbPam27 took place in an ancestor of the kinetoplastids, or even possibly at the dawn of the Glycomonada (Kinetoplastea and Diplonemea), as an orthologue of TbPam27 is found in *Diplonema sp.* ([@bib9]). This replacement could explain the transition to a single TIM complex ([Figure 10](#fig10){ref-type="fig"}). The core subunits of the ancestral TIM22 and TIM23-PAM complexes were likely very similar to the ones seen in extant yeast and animals ([Figure 10A](#fig10){ref-type="fig"}). TbTim17, a *T. brucei* TIM core subunit, is most closely related to Tim22, which forms the pore of the TIM22 complex ([@bib76]; [@bib58]). Thus, the transition from the ancestral state of two TIM complexes, to a single bifunctional TIM complex, required modifications of the TIM22 complex that would allow for compensation of the loss of the TIM23 complex. This means that an ancestral version of the trypanosomal TIM22 complex acquired the ability to translocate presequence-containing proteins. A speculative, yet plausible, scenario for this conversion looks as follows: A J domain-containing protein with a C-terminal TMD, the ancestor of TbPam27, that possibly arose by gene duplication, was recruited to the mitochondrial IM. This protein by chance interacted with the TIM22 complex and facilitated its interaction with TbmHsp70 ([Figure 10B](#fig10){ref-type="fig"}). This modification would have originally been neutral but could have been the first step towards a bifunctional TIM22 complex since it may have buffered eventual deleterious mutations that led to the loss of the TIM23 complex ([Figure 10C](#fig10){ref-type="fig"}). TimRhom I and TimRhom II are specifically associated with the presequence translocase ([@bib31]). The recruitment of these proteins as auxiliary components that facilitate the import of presequence-containing proteins, may have further promoted the transition to a single TIM complex ([Figure 10D](#fig10){ref-type="fig"}).

![Evolutionary scenario explaining the homologue replacement observed in the *T. brucei* PAM.\
(**A**) Ancestral situation predicted for LECA. TIM23 and TIM22 complexes are shown in light gray their and respective pore-forming subunits (Tim23, Tim22) are indicated. PAM subunits are shown in dark orange. Only Pam18, Pam16 and mHsp70 are shown. (**B**) The J domain-containing protein TbPam27 (light orange) is recruited to the ancient pro-kinetoplastid TIM22 complex and may has enabled interaction with mHsp70. Initially this would have been neutral. (**C**) The TIM22 complex of the ancient kinetoplastid acquires the capability to translocate presequence-containing proteins, possibly through the recruitment of the trypanosomal presequence translocase specific TimRhom I and TimRhom II (**D**). This allows for deleterious mutations and eventual disappearance of the trypanosomal TIM23 complex. TbPam18 and TbPam16 were retained because they either acquired a new as yet unknown function, or hold an overlooked ancestral role.](elife-52560-fig10){#fig10}

Importantly, the fact that we have identified orthologues of Pam18 and Pam16, which do not retain their ancestral function, puts a wrench into comparative genomic investigations that assume retention of ancestral features means conservation of function. Moreover, our findings raise the question of why Pam16 and Pam18 are still maintained in *T. brucei* and other kinetoplastids, even though they are no longer necessary for the presequence import pathway. We see two possibilities to explain this. The first is simply by neo-functionalization. The proteins may have picked up a novel function in the kinetoplastid lineage during the course of the evolution of the bifunctional TIM complex. The second possibility is that TbPam16 and TbPam18 have retained an as yet unknown ancestral function that is required in all eukaryotes, but has not been identified due to the focus on their role in the PAM complex. It is currently unclear what the functions of TbPam18 and TbPam16 are. Interestingly, unlike its yeast homologue, TbPam18 seems to be dually localized in the ER and in mitochondria. Moreover, retention of both proteins in all kinetoplastids and the fact that their RNAi-mediated ablation in *T. brucei* specifically interferes with growth of the procyclic but not the bloodstream forms provides both, further information and constraints regarding their possible function. Investigation of TbPam16 and TbPam18 functions will be an interesting topic for future research.

In summary, our study illustrates the intricate and variable paths evolution may take in different phylogenetic groups to achieve the same aim, namely, to import and sort more than 1000 cytosolically-synthesized proteins into mitochondria. Our work underscores the necessity to combine bioinformatics with functional data to allow for a meaningful comparative analysis that can provide insight into eukaryotic diversification.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                 Designation                                            Source or reference                                              Identifiers                                          Additional information
  (species) or resource                                                                                                                                                                                      
  ----------------------------- ------------------------------------------------------ ---------------------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------------------
  Gene (*Trypanosoma brucei*)   TbPam27                                                                                                                 TriTrypDB:Tb927.10.13830                             

  Gene (*T. brucei*)            TbPam18                                                                                                                 TriTrypDB:Tb927.8.6310                               

  Gene (*T. brucei*)            TbPam16                                                                                                                 TriTrypDB:Tb927.9.13530                              

  Gene (*T. brucei*)            Tb927.4.650                                                                                                             TriTrypDB:Tb927.4.650                                

  Gene (*T. brucei*)            TbmHsp70                                                                                                                TriTrypDB:Tb927.6.3740; Tb927.6.3750; Tb927.6.3800   

  Gene (*T. brucei*)            ACAD                                                                                                                    TriTrypDB:Tb927.8.1420                               

  Cell line (*T. brucei*)       29--13, procyclic                                      PMID: [10215027](https://www.ncbi.nlm.nih.gov/pubmed/10215027)                                                        

  Cell line (*T. brucei*)       L1γL262P, BSF                                          PMID: [23959897](https://www.ncbi.nlm.nih.gov/pubmed/23959897)                                                        

  Antibody                      Anti-HA (mouse, monoclonal)                            BioLegend                                                        901503 (MMS-101R)                                    WB(1:5000)

  Antibody                      Anti-myc (mouse, monoclonal)                           Invitrogen                                                       132500                                               WB(1:2000)

  Antibody                      Anti-ATOM40 (rabbit, polyclonal)                       Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:10000)

  Antibody                      Anti-TbTim17 (rat, polyclonal)                         Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:100)

  Antibody                      Anti-TimRhom I (rabbit, polyclonal)                    Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:150)

  Antibody                      Anti-VDAC (rabbit, polyclonal)                         Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:1000)

  Antibody                      Anti-Cox IV (rabbit, polyclonal)                       Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:1000)

  Antibody                      Anti-EF1a (mouse, monoclonal)                          Merk Millipore                                                   05--235                                              WB(1:10000)

  Antibody                      Anti-Cytochrome C (rabbit, polyclonal)                 Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:100)

  Antibody                      Anti-ATOM69 (rabbit, polyclonal)                       Other                                                                                                                 Previously produced in our lab\
                                                                                                                                                                                                             WB(1:50)

  Antibody                      Anti-mouse (goat, HRP-coupled)                         Sigma Aldrich                                                    A4416                                                WB(1:5000)

  Antibody                      Anti-mouse IRDye 680LT conjugated (goat)               LI-COR Biosciences                                               PN 926--68020                                        WB(1:20000)

  Antibody                      Anti-rabbit IRDye 800CW conjugated (goat)              LI-COR Biosciences                                               PN 926--32211                                        WB(1:20000)

  Recombinant DNA reagent       TbPam27 ORF RNAi (plasmid)                             This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam27 5'UTR RNAi (plasmid)                           This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam18 ORF RNAi (plasmid)                             This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam16 ORF RNAi (plasmid)                             This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       Tb927.4.650 ORF RNAi (plasmid)                         This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam27-3xmyc (plasmid)                                This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam27-3xHA (plasmid)                                 This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam27^wt^(plasmid)                                   This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam27^H77Q^(plasmid)                                 This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam18-3xHA (plasmid)                                 This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       TbPam16-3xHA (plasmid)                                 This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       Tb927.4.650-3xHA (plasmid)                             This paper                                                                                                            See Material and methods

  Recombinant DNA reagent       LDH-DHFR-3xHA (plasmid)                                PMID: [27991487](https://www.ncbi.nlm.nih.gov/pubmed/27991487)                                                        

  Recombinant DNA reagent       LDH-DHFR-3xmyc (plasmid)                               PMID: [27991487](https://www.ncbi.nlm.nih.gov/pubmed/27991487)                                                        

  Recombinant DNA reagent       MCP12ΔI-myc (plasmid)                                  PMID: [27991487](https://www.ncbi.nlm.nih.gov/pubmed/27991487)                                                        

  Commercial assay or kit       Prime-a-Gene labelling kit                             Promega                                                          U1100                                                Radioactive labelling of Northern probes

  Commercial assay or kit       SuperSignal West Femto maximum sensitivity substrate   Thermo Scientific                                                34096                                                Detection of BN-PAGE Western blot signals

  Chemical compound, drug       Tetracycline Hydrochloride                             Sigma Aldrich                                                    T7660                                                Induction of gene expression

  Chemical compound, drug       Aminopterin                                            Sigma Aldrich                                                    A1784                                                Presequence pathway intermediate stalling

  Chemical compound, drug       Sulfanilamide                                          Sigma Aldrich                                                    S9251-100G                                           Presequence pathway intermediate stalling

  Chemical compound, drug       Digitonin                                              Biosynth                                                         103203                                               Generation of crude mitochondrial fractions

  Chemical compound, drug       Lysine-L U-13C, U-15N                                  Euroisotop                                                       CNLM-291-H-0.5                                       SILAC labelling

  Chemical compound, drug       Arginine-L U-13C6, U-15N4                              Euroisotop                                                       CNLM-539-H-1                                         SILAC labelling

  Software, algorithm           GraphPad Prism, version 6.0 f                          GraphPad Software                                                [www.graphpad.com](http://www.graphpad.com)          Depiction of growth curves, quantifications and volcano blots.

  Software, algorithm           ImageJ                                                                                                                  <https://doi.org/10.1038/nmeth.2089>                 Densitometric quantifications

  Other                         EZView Red Anti-c-myc affinity gel                     Sigma Aldrich                                                    E6654                                                CoIP

  Other                         Anti-HA affinity matrix                                Roche                                                            11815016001                                          CoIP
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Protein similarity network analyses {#s4-1}
-----------------------------------

A database that comprised 46 proteomes from diverse representative eukaryotes, with an emphasis on euglenozoans (i.e., kinetoplastids, euglenoids, diplonemids), was assembled. HMMER searches ([@bib23]) using the Pfam profile Hidden Markov Models (pHMMs) for the DnaJ (PF00226) and Pam16 (PF03656) domains, and leniant E-values of 0.1 in order to capture divergent DnaJ domains, were performed against each proteome individually. The hit sequences were then used to build a local custom database of DnaJ- and Pam16 domain-containing proteins. Additionally, reciprocal BLASTp searches ([@bib2]) using ScPam16 and ScPam18 and the putative TbPam16 and TbPam18 as queries (identified through the network analysis) were performed. This was done to retrieve highly divergent proteins in some eukaryotes (e.g. in euglenozoans) that could not be captured from the curated Pfam profile HMMs. The reciprocal best BLAST hits retrieved were then added to the database of DnaJ and Pam16 domain-containing proteins built with pHMM searches. Duplicates were removed and the redundancy of the database was further reduced with CD-HIT and a threshold of 95% identity ([@bib41]). An all-against-all BLAST search was performed for this database using the BLOSUM50 matrix and an E-value of 0.1 as a threshold. The similarities (i.e., local alignments) among all DnaJ- and Pam16-domain containing proteins were visualized as a 2D protein similarity network with the software CLANS ([@bib26]). Each DnaJ domain-containing protein (a node) is iteratively placed (for at least 1000 rounds) in a two-dimensional space according to attraction and repulsion values derived from BLAST P-values (edges). Edges correspond to P-values and nodes to protein sequences. Some isolated peripheral nodes and weakly intraconnected clusters were removed for a better visualization of the core similarity network.

Assembly of diplonemid transcriptomes {#s4-2}
-------------------------------------

Illumina short reads for RNA-Seq experiments of the diplonemids *Diplonema ambulator* (SRR5998378 and SRR5998379), *Diplonema* sp. (SRR5998375 and SRR5998376), and *Rhynchopus euleeides* (SRR5998382 and SRR5998383) were downloaded from NCBI SRA. Quality assessments of the RNA-Seq short raw reads were done with FastQC v0.11.7. The Illumina short reads were then quality-filtered with Trimmomatic v0.39 ([@bib6]). Quality filtered reads were assembled into transcriptomes with Trinity v2.8.4 ([@bib29]). Proteomes was predicted from the assembled transcriptome with TransDecoder v5.5.0 ([@bib29]).

Phylogenetic analysis {#s4-3}
---------------------

Clusters in the similarity network corresponding to Pam16, Pam18, Pam27 and Tb927.4.650 protein families were retrieved and aligned to the Pfam Pam16 pHMM ([@bib23]). Non-aligned ends were trimmed and two extremely divergent sequences were also removed. Phylogenetic inference was performed under the maximum-likelihood framework using the software IQ-TREE ([@bib51]). The best-fitting model was found to be LG+R5 by IQ-TREE\'s ModelFinder ([@bib36]). Statistical branch support was assessed with Shimodaira-Hasegawa approximate Likelihood Ratio Test (SH-aLRT) and UltraFast Bootstrap two with NNI optimization (UFBoot2+NNI) ([@bib34]).

Transgenic cell lines {#s4-4}
---------------------

Transgenic *T. brucei* cell lines were generated using the procyclic strain 29--13 ([@bib75]) or the bloodstream form (BSF) strain New York single marker variant F1γL262P ([@bib20]). Procyclic forms were cultivated at 27°C in SDM-79 ([@bib8]) supplemented with 10% (v/v) fetal calf serum (FCS). BSF cells were grown at 37°C in HMI-9 ([@bib33]) containing 10% FCS (v/v).

To produce plasmids for ectopic expression of C-terminal triple c-myc- or HA-tagged TbPam27 (Tb927.10.13830), TbPam18 (Tb927.8.6310), TbPam16 (Tb927.9.13530), Tb927.4.650 and ACAD (Tb927.8.1420) the complete ORFs of the respective gene was amplified by PCR. The PCR products were cloned into a modified pLew100 vector ([@bib75]; [@bib5]) which contains either a puromycin or a blasticidin resistance gene instead of phleomycin as well as a triple c-myc- or HA-tag ([@bib53]). The triple c-myc-tagged, truncated (nt 274--912) ORF of MCP12 (Tb927.10.12840) and both of the triple c-myc- or HA-tagged LDH-DHFR fusion proteins have been described previously ([@bib31]).

RNAi cell lines were prepared using the identical pLew100-derived vector described above. It allows the generation of a stem-loop construct by the insertion of the RNAi inserts in opposing directions. The loop is formed by a 460 bp spacer fragment. The RNAi targets the indicated nt of the ORFs of TbPam27 (nt 5--450), TbPam18 (nt 8--353), TbPam16 (nt 15--485) and Tb927.4.650 (nt 105--622) as well as the 5' untranslated region (UTR) of TbPam27 (nt (−422)-(−66)). RNAi against the ORF of TbmHsp70 (Tb927.6.3740, Tb927.6.3750, Tb927.6.3800) has been described previously ([@bib71]).

The H77Q mutant of TbPam27 (TbPam^H77Q^) was constructed by site-directed mutagenesis using complementary primers that carry the desired mutation, as well as a down- and an upstream primer. PCR products of the wildtype and the H77Q mutant version of the ORF of TbPam27 were cloned into a pLew100 derived vector lacking the epitope tag.

Digitonin extraction {#s4-5}
--------------------

Crude mitochondria-enriched fractions were obtained by incubating 1 × 10^8^ cells on ice for 10 min in 0.6 M sorbitol, 20 mM Tris-HCl pH 7.5, 2 mM EDTA pH 8 containing 0.015% (w/v) digitonin for selective solubilization of plasma membranes. Centrifugation (5 min, 6'800 g, 4°C) yielded a supernatant that is enriched in cytosolic proteins and a mitochondria-enriched pellet. Equivalents of 2 × 10^6^ cells of each fraction were analyzed by SDS-PAGE and subsequent Western blotting to demonstrate mitochondrial localization for proteins of interest. Cell lines were induced with tetracycline (Tet) for 24 hr to visualize epitope-tagged proteins.

Alkaline carbonate extraction {#s4-6}
-----------------------------

In order to separate soluble or loosely membrane associated proteins from integral membrane proteins, a mitochondria-enriched pellet was generated as described above and resuspended in 100 mM Na~2~CO~3~ pH 11.5, incubated on ice for 10 min and centrifuged (10 min, 100'000 g, 4°C). Equivalents of 2 × 10^6^ cells of each fraction were subjected to SDS-PAGE and Western blotting.

Protease protection assay {#s4-7}
-------------------------

A mitochondria-enriched digitonin pellet from 1 × 10^7^ cells per sample was generated as described above. This pellet was resuspended in 250 mM sucrose, 80 mM KCl, 5 mM MgAc, 2 mM KH~2~PO~4~ and 50 mM HEPES in a total volume of 50 μl and the indicated additions of proteinase K and 0.5% (v/v) Triton-X100. After 15 min incubation on ice, the reactions were stopped by adding PMSF to 5 mM. Samples without Triton X100 were centrifuged (5 min, 6800 g, 4°C) and all samples were resuspended in SDS loading buffer. Of each sample, 1 × 10^6^ cell equivalents were subjected to SDS-PAGE and Western blotting.

Co-immunoprecipitation {#s4-8}
----------------------

Digitonin-extracted mitochondria-enriched fractions of 1 × 10^8^ cells expressing the epitope-tagged protein of interest were solubilized for 15 min on ice in 20 mM Tris-HCl pH7.4, 0.1 mM EDTA, 100 mM NaCl, 10% glycerol containing 1X Protease Inhibitor mix (Roche, EDTA-free) and 1% (w/v) digitonin. After centrifugation (15 min, 20'000 g, 4°C), the lysate (input) was transferred to either 50 μl of HA bead slurry (anti-HA affinity matrix, Roche) or 30 μl c-myc bead slurry (EZview red anti-c-myc affinity gel, Sigma) both of which had been equilibrated in wash buffer (20 mM Tris-HCl pH 7.4, 0.1 mM EDTA, 100 mM NaCl, 10% glycerol, 0.2% (w/v) digitonin). After incubating at 4°C for 1 hr, the supernatant containing the unbound proteins was removed. The bead slurry was washed three times with wash buffer and the bound proteins were eluted by boiling the resin for 5 min in 2% SDS in 60 mM Tris-HCl pH 6.8 (IP). Five percent of both the input and the unbound proteins and 100% of the IP sample were subjected to SDS-PAGE and Western blotting.

For the stalled import intermediate, LDH-DHFR-HA expression was induced by tetracycline and respective cell cultures were supplemented with 1 mM sulfanilamide and 50 μM aminopterine (AMT) 12 hr before the experiment ([@bib31]). CoIP was performed as described above.

Blue native-PAGE {#s4-9}
----------------

Digitonin-extracted mitochondria-enriched fractions were incubated for 15 min on ice in 20 mM Tris-HCl pH 7.4, 50 mM NaCl, 10% glycerol, 0.1 mM EDTA, 1 mM PMSF containing 1% (w/v) digitonin in order to solubilize mitochondrial membranes. After a clearing spin (15 min, 20'817 g, 4°C) the samples were separated on 4--13% gradient gels. Prior to Western blotting the gel was incubated in SDS-PAGE running buffer (25 mM Tris, 1 mM EDTA, 190 mM glycine, 0.05% (w/v) SDS) in order to facilitate the transfer of proteins to the membrane.

RNA extraction and northern blotting {#s4-10}
------------------------------------

Acid guanidinium thiocyanate-phenol-chloroform extraction according to [@bib11] was used for isolation of total RNA from uninduced and induced (2 days) RNAi cells. RNA samples were separated on a 1% agarose gel in 20 mM MOPS buffer supplemented with 0.5% formaldehyde. Northern probes were generated from gel-purified PCR products corresponding to the RNAi inserts mentioned above and radioactively labelled by means of the Prime-a-Gene labelling system (Promega).

SILAC proteomics and IP {#s4-11}
-----------------------

TbPam27 ORF RNAi cells or cells that allow inducible expression of epitope-tagged proteins were washed in PBS and taken up in SDM-80 ([@bib39]) supplemented with 5.55 mM glucose, either light (^12^C~6~/^14^N~χ~) or heavy (^13^C~6~/^15^N~χ~) isotopes of arginine (1.1 mM) and lysine (0.4 mM) (Euroisotop) and 10% dialyzed FCS (BioConcept, Switzerland). To guarantee complete labeling of all proteins with heavy amino acids, the cells were cultured in SILAC medium for 6--10 doubling times.

For the TbPam27 SILAC RNAi experiment, the cells were induced with tetracycline for 1.5 days. Directly before cell lysis, uninduced and induced cells were mixed in a 1:1 ratio. Of the mixed cells, digitonin-extracted mitochondria-enriched pellets were generated.

For the ACAD, TbPam18 and TbPam16 SILAC-IP experiments, digitonin-extracted mitochondria-enriched pellets of 2 × 10^8^ uninduced and induced cells were subjected to CoIP as described above.

The TbPam27 SILAC RNAi experiment and all SILAC-IPs were done in three biological replicates including a label-switch and analyzed by liquid chromatography-mass spectrometry (LC-MS).

LC-MS and data analysis {#s4-12}
-----------------------

Proteins of mitochondrial fractions prepared from SILAC-labeled induced and uninduced TbPam27-RNAi cells (20 µg per replicate; n = 3) were reduced, alkylated, and tryptically digested as described before ([@bib54]). To reduce sample complexity, peptides were fractionated by high-pH reversed-phase chromatography using StageTips ([@bib60]). Peptides were dried *in vacuo*, resuspended in 10 mM NH~4~OH and loaded onto StageTips that were equilibrated with 10 mM NH~4~OH. A step gradient of 0, 2.7, 5.4, 9.0, 11.7, 14.4, 36% and 65% (v/v) acetonitrile, diluted in 10 mM NH~4~OH, was applied for peptide elution. Proteins present in eluates of ACAD, TbPam16 and TbPam18 SILAC-IPs (n = 3 each) were processed following a gel-based approach. Reduction, alkylation and tryptic in-gel digestion of proteins were performed as described ([@bib54]) and the resulting peptide mixtures were desalted using StageTips. Peptides eluted from StageTips were dried *in vacuo*, reconstituted in 0.1% trifluoroacetic acid, and analyzed by LC-MS using a Q Exactive Plus (samples of TbPam27-RNAi experiments and TbPam16 and TbPam18 SILAC-IPs) or an Orbitrap Elite (ACAD SILAC-IPs) (Thermo Fisher Scientific, Germany) coupled to an UltiMate 3000 RSLCnano HPLC system (Thermo Fisher Scientific, Germany). For the elution of peptides, the following solvent systems were used: 0.1% (v/v) formic acid (FA) (solvent A) and 86% (v/v) acetonitrile (ACN)/0.1% (v/v) FA (solvent B) for LC-MS analyses using the Q Exactive and 0.1% (v/v) FA/4% (v/v) DMSO (solvent A\') and 50% (v/v) methanol/30% (v/v) ACN/0.1% (v/v) FA/4% (v/v) DMSO (solvent B\') for analyses using the Orbitrap Elite. Peptides generated in TbPam27-RNAi experiments were eluted with a solvent gradient increasing from 4--40% B in 50 min followed by 40--95% B in 5 min and 5 min at 95% B. Peptides of TbPam16 and TbPam18 complexes were eluted with 1--20% B in 103 min, 20--42% B in 50 min, 42--95% B in 2 min and 5 min at 95% B, and for the elution of peptides from ACAD SILAC-IPs, a gradient ranging from 1--65% B\' in 30 min followed by 65--95% B\' in 5 min and 5 min at 95% B\' was applied. The flow rates were 300 nl/min.

The Q Exactive Plus instrument was operated with the following mass spectrometric parameters: MS scan range, *m/z* 375--1,700; resolution, 70,000 (at *m/z* 200); target value, 3 × 10^6^ ions; max injection time, 60 ms; TOP12-higher-energy collisional dissociation of multiply charged peptides; dynamic exclusion time, 45 s. For MS analyses at the Orbitrap Elite, the settings were as follows: MS scan range, *m/z* 370--1,700; resolution, 120,000 (at *m/z* 400); target value, 1 × 10^6^ ions; max injection time, 200 ms; TOP5-collision-induced dissociation of multiply charged peptides; dynamic exclusion time, 45 s.

MaxQuant/Andromeda (version 1.5.4.0 for ACAD SILAC-IPs and 1.5.5.1 for the other samples \[[@bib13]; [@bib14]\] was used for protein identification and relative quantification. MS/MS data were searched against all entries for *T. brucei* TREU927 retrieved from the TriTryp database (version 8.1) using MaxQuant default settings except that one unique peptide was sufficient for protein identification. Lys8 and Arg10 were selected as heavy labels, carbamidomethylation of cysteine as fixed, and N-terminal acetylation and oxidation of methionine as variable modifications. Protein abundance ratios were calculated based on unique peptides and at least one SILAC peptide pair. Lists of proteins identified and quantified in the analysis of TbPam27-RNAi experiments as well as SILAC-IPs of ACAD, TbPam16 and TbPam18 are provided in [Figure 3---source datas 1](#fig3sdata1){ref-type="supplementary-material"}--[3](#fig3sdata3){ref-type="supplementary-material"} and [Figure 9---source data 1](#fig9sdata1){ref-type="supplementary-material"}.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The mitochondrial protein import machinery of Trypanosomes differs from that of fungi and animals. In contrast to fungi and animals, only one TIM machinery is used by the proteins that translocate to the mitochondrial matrix and the proteins, such as carriers, that integrate into the inner mitochondrial membrane. Interestingly, the study shows that a novel protein TbPam27 takes the role of presequence translocase associated motor (PAM) and its J protein, Pam18, in the TIM complex serving an important role during the protein import into mitochondria. The study provides an interesting example of the functional and architectural replacement of proteins during the transition into bifunctional TIM complex in the evolution.

**Decision letter after peer review:**

Thank you for submitting your article \"Homologue replacement in the import motor of the mitochondrial inner membrane of trypanosomes\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Dominique Soldati-Favre as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Patrick R D\' Silva (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers are overall positive, however they identified several issues that must be addressed in the revision of this work.

All of them agree that the this work does not sufficiently demonstrate the interactions as well as the role Pam27 in relation to other Pam proteins at the TbTIM complex.

Concerning the architecture of TIM and Pam27 specifically, the authors should examine immunoprecipitation experiments for other known components of the TIM complex, either via antibodies and/or mass spectrometry analyses. The reverse immunoprecipitations should also be performed, also using Pam18 and Pam16 as baits. All the experiments addressing the assemblies of the TbTIM complex should be carefully controlled including negative controls.

The reviewers are not convinced that a single entity ThTIM complex exists. Another possibility is that they are several sub-pools of this complexes, some of them without Pam27. The authors should consider some of the following experiments to address this issue: testing whether TbPam18 and TbPam16 are recruited to TIM-complex in the absence of TbPam27, testing the levels of TbPam18 and TbPam16 in TbPam27 RNAi cells. An interesting input can also be obtained from BN analyses.

A functional aspect of the study must be strengthened in general, and also to provide more insights into functionally identical vs. diverse complex assemblies. TbPam16, TbPam18 and TbPam27 are all essential proteins. However, the roles of TbPam16 and TbPam18 for protein import unclear. The authors should elucidate this in more depth, by utilizing import assays, and also for example by mass spectrometry of cells in which these components were depleted.

Other specific points of reviewers should or may be considered prior to submission of the revised version:

Reviewer 1:

1\) Figure 2 -- evidence for inner membrane localisation is weak and indirect. This should be done using a mitochondrial subfractionation assay, probing with and without protease.

2\) Figure 4 uses MCP1Δ as a control for LDH-DHFR, however given this is control precursor is not fused to DHFR it is not an appropriate control? Given this, the outcome of this figure, i.e. carrier biogenesis is not affected is not convincing enough. The authors should also show both OM and IM IP controls for DHFR blocking as spans both membrane.

3\) Figure 5, Blots in A (right panel) are inconsistent with the time frame of graph (missing day 4) and remainder of blots shown in figure.

4\) Figure 7, need complementary SDS PAGE analysis to show levels of Myc protein and levels of TIM subunits. In panel B the authors suggest the carrier intermediate is not affected (in the text), but it clearly is when looking at the data. This data should not be misinterpreted and the possibility that carrier import is also affected should be considered.

Figure legend and description of which samples go into (C) is not clear. Perhaps also state in axis label what the band intensity was calculated from.

Top left: what does the 34.4% correspond too? Not mentioned in main text or legend.

Top right: label some of most significant presequence-containing proteins.

Bottom left: how is the 8.3% calculated? Poorly described in text/not at all in legend.

Bottom right: make bottom left (and give letters) as referred to first in text.

Reviewer 2:

Figure 8 contains little information and should be shifted into the supplements. Instead, the mass spec data shown in Figure 9 should be further analyzed. For example, measurements of the proteomes after short or longer times of ablation might allow to distinguish direct from indirect effects. In particular proteins would be interesting, which disappear very early after downregulation of TbPam27.*Reviewer 3:*

1\) VDAC is recently shown to interact with yeast TIM22-complex for the efficient import of Carrier proteins (https://doi.org/10.1016/j.molcel.2018.12.014); therefore, the observed pull-down of TbTim17 and VDAC with Tb927.4.650-HA might be specific (although having lesser affinity), thereby Tb927.4.650 could be a subunit of Tb TIM complex required for carrier protein import. Similarly, VDAC might be cooperating with the TbTIM complex during carrier protein import.
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Author response

> The reviewers are overall positive, however they identified several issues that must be addressed in the revision of this work.
>
> All of them agree that the this work does not sufficiently demonstrate the interactions as well as the role Pam27 in relation to other Pam proteins at the TbTIM complex.
>
> Concerning the architecture of TIM and Pam27 specifically, the authors should examine immunoprecipitation experiments for other known components of the TIM complex, either via antibodies and/or mass spectrometry analyses.

The composition of the trypanosomal TIM complex has been extensively analyzed by proteomic analysis of SILAC immunoprecipitations (IP) using the tagged TIM subunits TbTim17, TbTim42 and TbTim13 (a TIM complex-associated small TIM chaperone) as baits (1). Moreover, the same analysis was also done using a stalled presequence-containing precursor protein or a stalled mitochondrial carrier as a bait (1). In the revised manuscript we have now complemented this data by a new SILAC-IP, which uses the tagged TIM subunit ACAD as a bait (new Figure 3---source data 1). A summary of the six reciprocal IPs is provided in the table shown in \"Figure 3---figure supplement 1\" of the revised manuscript. It shows that TbPam27 is enriched in 5 out of 6 IPs, whereas TbPam18, TbPam16 and Tb927.4.650 are either not detected or not significantly enriched in any of the 6 IPs (compared to VDAC which is used as a control).

The new analysis is discussed in the revised manuscript (subsection \"TbPam27, but not TbPam18, TbPam16 or Tb927.4.650, is associated with the TIM complex\", second paragraph and subsection \"TbPam27 is part of the active presequence translocase\", third paragraph).

> The reverse immunoprecipitations should also be performed, also using Pam18 and Pam16 as baits. All the experiments addressing the assemblies of the TbTIM complex should be carefully controlled including negative controls.

We preformed the reverse SILAC proteomics-based IPs using C-terminally tagged TbPam18 and TbPam16 as baits, as suggested (new Figure 3B in the revised manuscript). Again, the results were very clear, none of the detected TIM subunits in these experiments was significantly enriched in either of the two IPs. This indicates that --- in contrast to TbPam27 --- neither TbPam18 nor TbPam16 interacts with the TIM complex. --- Further results we gained from these experiments were: i) that TbPam16 essentially exclusively interacts with TbPam18, and that ii) TbPam18 likely has a dual localization in the mitochondrion and the ER. TbPam16 and TbPam18 have predicted N-terminal mitochondrial targeting sequences, it is therefore unlikely that the C-terminal tag interferes with their localization.

The new results are discussed in the revised manuscript (subsection \"TbPam27, but not TbPam18, TbPam16 or Tb927.4.650, is associated with the TIM complex\").

> The reviewers are not convinced that a single entity ThTIM complex exists. Another possibility is that they are several sub-pools of this complexes, some of them without Pam27.

This is a misunderstanding, we don\'t claim that there is only a single entity of the TIM complex. In fact the pulldown experiments using the two different arrested import substrates show that TbPam27 is preferentially associated with the precursor and not the carrier translocase. --- What we claim is that there is no evidence that either TbPam18 or TbPam16 is associated with any form of the TIM complex that we can detect in six different SILAC-IPs (see new Figure 3---figure supplement 1 and new Figure 3B in the revised manuscript).

> The authors should consider some of the following experiments to address this issue: testing whether TbPam18 and TbPam16 are recruited to TIM-complex in the absence of TbPam27, testing the levels of TbPam18 and TbPam16 in TbPam27 RNAi cells. An interesting input can also be obtained from BN analyses.

We did the requested experiment (new Figure 6---figure supplement 1 of the revised manuscript). The results show i) that there is no compensatory accumulation of TbPam16 or TbPam18 upon ablation of TbPam27 and ii) that pull down experiments in TbPam27 ablated cells using tagged versions of TbPam16 or TbPam18 still do not recover the TIM subunits TbTim17 or TimRhom I.

The new results are discussed in revised manuscript (subsection \"Neither TbPam16 nor TbPam18 is required for mitochondrial protein import\", last paragraph).

We tried to do BN-PAGE analysis, however, the tagged TbPam18 or TbPam16 could not be detected in this type of analysis.

> A functional aspect of the study must be strengthened in general, and also to provide more insights into functionally identical vs. diverse complex assemblies. TbPam16, TbPam18 and TbPam27 are all essential proteins. However, the roles of TbPam16 and TbPam18 for protein import unclear. The authors should elucidate this in more depth, by utilizing import assays, and also for example by mass spectrometry of cells in which these components were depleted.

*in vitro* import assays are feasible with mitochondria from wild-type *T. brucei*, but they are much more difficult with RNAi cells. For some cells linesthey do not work at all, even when using mitochondria from uninduced cells, which should not show a phenotype. Moreover, we only have a single substrate that works efficiently. The information that can be gained from such *in vitro* import experiments is therefore limited.

SILAC MS analysis of TbPam18 and TbPam16 RNAi cells could be done. However, the manuscript is about TbPam27 and we don\'t claim to know what the function of TbPam18 and TbPam16 is, except that they are not involved in import of presequence-containing proteins.

Instead we decided to do another experiment, which provides important information regarding the function of TbPam16 and TbPam18. *T. brucei* has a complex life cycle, alternating between an insect and a mammalian host. Mitochondrial protein import is essential for both insect stage and bloodstream forms of the parasite. We now show that only TbPam27, but neither TbPam16 nor TbPam18, is essential for growth of the bloodstream form (new Figure 5C and new Figure 6B of the revised manuscript). These results are consistent with the role of TbPam27 as a PAM subunit in mitochondrial protein import. Moreover, they show that the essential function of TbPam16 and TbPam18 is restricted to the insect stage of the parasite and, therefore, cannot be mitochondrial protein import.

The new results are discussed in the revised manuscript (subsection \"TbPam27 with an intact J domain is essential for mitochondrial protein import\", second paragraph and subsection \"Neither TbPam16 nor TbPam18 is required for mitochondrial protein import\", second paragraph).

> Other specific points of reviewers should or may be considered prior to submission of the revised version:
>
> Reviewer 1:
>
> 1\) Figure 2 --- evidence for inner membrane localisation is weak and indirect. This should be done using a mitochondrial subfractionation assay, probing with and without protease.

Mitochondrial subfractionation assays are possible with large amounts of cells on the preparative scale using sucrose gradient centrifugation (this data is provided for TbPam27 in Figure 2D of the revised manuscript) but they do not work on the analytical scale. --- However, we now show that TbPam27, TbPam18 and TbPam16 are protease-resistant in digitonin-purified crude mitochondrial fractions indicating that all three proteins are localized in the mitochondrial inner and not the outer membrane. --- It should be considered in this context that for TbPam18 the interpretation of the result is more complex, since it is likely dually localized to the mitochondrion and the ER.

The new results are discussed in the revised manuscript (subsection \"TbPam27, but not TbPam18, TbPam16 or Tb927.4.650, is associated with the TIM complex\", first paragraph).

> 2\) Figure 4 uses MCP1Δ as a control for LDH-DHFR, however given this is control precursor is not fused to DHFR it is not an appropriate control? Given this, the outcome of this figure, i.e. carrier biogenesis is not affected is not convincing enough. The authors should also show both OM and IM IP controls for DHFR blocking as spans both membrane.

We are not sure we understand the reviewers concern. The two import intermediates have been described in detail in a previous publication (1). There it was also shown that the stalled presequence substrate spans both membranes, whereas the truncated carrier intermediate accumulates in the inner membrane only. Fusing the truncated carrier substrate to DHFR would block both the presequence and the carrier pathway.

> 3\) Figure 5, Blots in A (right panel) are inconsistent with the time frame of graph (missing day 4) and remainder of blots shown in figure.

The missing data for day 4 has been added

> 4\) Figure 7, need complementary SDS PAGE analysis to show levels of Myc protein and levels of TIM subunits. In panel B the authors suggest the carrier intermediate is not affected (in the text), but it clearly is when looking at the data. This data should not be misinterpreted and the possibility that carrier import is also affected should be considered.

The complementary SDS PAGE analysis has been added (Figure 7 of the revised manuscript). It monitors the levels of the TIM complex core subunit TbTim17 as well as the levels of LDH-DHFR and the MCP12ΔI substrates, respectively. (Note that for the LDH-DHFR substrate addition of aminopterin results in shift of the band on the SDS gel).

It is stated in the text that \"...accumulation of the truncated MCP12ΔI was not affected for at least two days\". This is indeed what Figure 7B shows. --- We do see an effect on the carrier intermediate, but only after three days (and even then it is much less than in the case of the presequence intermediate), but these are likely pleiotropic effects caused by the growth arrest, which starts after day one. --- It is important to note that eventually import of all proteins will be affected since import of some TIM core subunits (e.g. ACAD), which are required for import of both presequence-containing as well as mitochondrial carrier proteins, have predicted mitochondrial targeting sequences.

> Figure legend and description of which samples go into (C) is not clear. Perhaps also state in axis label what the band intensity was calculated from.

The legend has been modified

> Top left: what does the 34.4% correspond too? Not mentioned in main text or legend.

It is now mentioned in the revised manuscript (subsection \"Ablation of TbPam27 preferentially affects presequence-containing proteins\", first paragraph)

> Top right: label some of most significant presequence-containing proteins.

Some proteins have been labeled in the revised figure.

> Bottom left: how is the 8.3% calculated? Poorly described in text/not at all in legend.

The sentence in question (subsection \"Ablation of TbPam27 preferentially affects presequence-containing proteins\", first paragraph) has been modified.

> Bottom right: make bottom left (and give letters) as referred to first in text.

The figure has been rearranged and re-labeled

> Reviewer 2:
>
> Figure 8 contains little information and should be shifted into the supplements.

The reviewers put a lot of emphasis on TbPam18 and TbPam16 we would, therefore, like to keep it as a main figure.

> Instead, the mass spec data shown in Figure 9 should be further analyzed. For example, measurements of the proteomes after short or longer times of ablation might allow to distinguish direct from indirect effects. In particular proteins would be interesting, which disappear very early after downregulation of TbPam27.

SILAC proteomics experiments are costly, which is why we analyzed a single time point only. However, we believe that the extent to which proteins get downregulated after ablation of TbPam27, can serve as a proxy for a time course. Thus, we hypothesize that the more efficiently downregulated proteins (we use a cutoff of 1.5-fold) are directly affected by the lack of TbPam27. Having said that, it is important to realize that these are complex *in vivo* experiments and there are always parameters that cannot be controlled, which may confound the results for a few proteins (e.g. the degree of downregulation is influenced by the half-life of the protein in question). The power of the analysis comes from the fact that we have data for 899 different proteins (83% of the mitochondrial proteome).

> Reviewer 3:
>
> 1\) VDAC is recently shown to interact with yeast TIM22-complex for the efficient import of Carrier proteins (https://doi.org/10.1016/j.molcel.2018.12.014); therefore, the observed pull-down of TbTim17 and VDAC with Tb927.4.650-HA might be specific (although having lesser affinity), thereby Tb927.4.650 could be a subunit of Tb TIM complex required for carrier protein import. Similarly, VDAC might be cooperating with the TbTIM complex during carrier protein import.

The amount of TbTim17 and VDAC detected in the Tb927.4.650 pull downs is approximately the same as in the other tested cell lines, which is why we considered it not to be specific. It is true that we cannot exclude a low affinity association of the two proteins with Tb927.4.650. However, we did not further investigate Tb927.4.650 in the present study because, its ablation does not cause a growth arrest.
